Abstract

Lumpy skin disease (LSD) is an infectious economically important viral disease of cattle. Lumpy skin disease virus (LSDV) is still circulating in Egypt, despite the annual mass vaccination with sheep pox virus vaccine recommended by the Egyptian authorities. This study was carried out on two farms of pregnant Holstein cows vaccinated with Bovivax LSD-N® Vaccine (farm I) and Servac Capri-C vaccine® (farm II). After 40-60 days post-vaccination, mild clinical signs were detected in 3% of cows on the farm I whereas a more severe clinical infection was developed in 40% of cows on farm II. LSDV was isolated on the chorioallantoic membrane (CAM) of 11 days old embryonated chicken egg (ECEs) and Madin Darby bovine kidney (MDBK) tissue culture. LSDV was identified in collected skin tissues by Transmission electron microscopy (TEM) and histopathological examination. Finally, LSDV was confirmed by polymerase chain reaction (PCR) amplification at 192 base pair (bp) of the P32 gene and two samples were selected for DNA sequencing. LSDV developed characteristic pock lesions in inoculated ECEs. MDBK cell culture developed a prominent LSDV cytopathic effect at the 3rd passage. Viral particles were detected in the cytoplasm of both epidermal cells and dermal macrophages by TEM. Histopathological examination revealed different lesions correlated withLSDV infection age. LSDV was confirmed in all tested samples by PCR. Our strains (Dakahlia- 2020-1 and Dakahlia- 2020-2) were closely related to other Egyptian LSDV strains on GenBank with 98.2%-100% identity. The present study proved conclusive evidence that the live attenuated sheep poxvirus vaccine poorly protects Egyptian cattle against LSDV, while the LSDV Neethling strain vaccine gave a promising and sufficient protection rate

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call